Dr Umapati Narasinha Hegde

Vice Chairman, Dept. of Nephrology

Personal Information

Present Address
Consultant Nephrologist
Vice chairman, Department of Nephrology
Muljibhai Patel Urological Hospital
Dr.Virendra .Desai Road,
Nadiad-387001, Gujarat
India
Phone
(0268)-2520323-2520332
Residence
(0268)2521238
Mobile No
09426043141
Fax No
2520248
Email Id
umapatih@gmail.com; hegumapati@gmail.com
Date of Birth
20th July 1971

Educational Qualifications

M.B.B.S
J. N.M. College Belgaum, Karnataka.
Karnataka University Dharwad
Dec 1993
First
MD(Internal Medicine)
Lokamanya Tilak Municipal Medical college and General Hospital.
University of Mumbai
Jan 2000
First
DNB (Nephrology)
Muljibhai Patel Urological Hospital, Nadiad , Gujarat
National Board of Examinations, New-Delhi
May 2004
First
Fellow of ISN (FISN)
University of Arkansas for Medical Sciences,USA
International Society of Nephrology
May 2006

Working Experience

June 1989 –March 1995.
Trained in J.N.Medical College Belgaum, Karnataka and acquired MBBS degree in December 1993.As a part of Compulsory internship programme (March 1994 to March 1995) I was trained at Civil Hospital Belgaum, Karnataka.

February 1997- January 2000.
Worked as medical registrar in Internal medicine at Lokamanya Tilak  Municipal  Medical college and General Hospital, Mumbai. Gained efficiency in the treatment of medical diseases, Intensive care management including cardiac emergency and ventilator management. At the end of the training period awarded MD (Internal medicine) at first attempt.

February  2000- June 2000
Worked as a resident in the Department of medicine at Breach candy Hospital, Mumbai.

July 2000-May 2004
Joined as nephrology resident at Muljibhai Patel Urological center Nadiad, Gujarat.
Registered for Diplomat of National Board in Nephrology super-specialty as trainee at M.P.U.Hospital Nadiad, Gujarat, since January 2001. I was trained in general nephrology, dialysis and transplantation. I have efficiency in interventions such as central venous catheterization (temporary), renal biopsy (native and graft) under real time ultrasound. I have efficiency in performing and interpreting ultrasound of Kidney ureter and bladder. At the end of training, I appeared for DNB Nephrology theory (December 2003) and practical  (May 2004) and passed in first attempt.

May 2006-Nov 2006 (ISN fellowship)
Selected for International Society of Nephrology Fellowship at University of Arkansas for Medical Sciences (UAMS) United States, which is one of the centers starting Slow Low Efficient Dialysis (SLED). I got proficiency in continuous renal replacement therapy (CRRT), Slow Low Efficient Dialysis (SLED) and clinical nephrology. Acquired knowledge in the field of Cadaveric kidney transplantation.

May 2004 till date
Presently working as a Consultant Nephrologist at Muljibhai Patel Urological Hospital Nadiad. Guajat, which is 150-bedded hospital accredited for DNB training in Nephrology and Urology. It has general nephrology, Pediatric nephrology services and active live related renal transplant programme. It has facility for maintenance hemodialysis for long-term and also as bridge to renal transplant. We perform 140-150 renal transplant every year. Started  ABO incompatible renal transplant in 2013.
Our hospital has small number of CAPD patients. It has an active vascular interventional programme in Reno-vascular diseases (both Native and graft) and vascular access.  I have experience in performing renal angiographies. It has 2 DNB fellowship seats in the field of nephrology. In addition to the management of patients I have teaching experience for the DNB nephrology fellows.

Papers presented

  1. Hegde UN,Gang SD, Rajapurkar MM.. Recovery of renal function following deobstruction in obstructed urinary system. West-Zone Chapter: Indian Society of Nephrology at Vadodara -December 2001.
  2. Hegde UN,Gang SD, Rajapurkar MM. Comparison  of efficacy of  Arpimune ME( RPG Life science) with Sandimune Neoral (Noavrtis) Indian Society of Nephrology  at Jaipur 2002.
  3. Bhosle N,Hegde UN,Gang SD, Rajapurkar MM. Outcome of renal transplant in reflux nephropathy. Indian Society of Nephrology  at Jaipur 2002.
  4. Hegde UN,Gang SD, Rajapurkar MM. Severe liver disease in early post transplant period: Significance of Positive HCV –RNA/ absent Anti -HCV Antibody, West-Zone Chapter: Indian Society of Nephrology at Aurangabad.
  5. Hegde UN,Gang SD, Desai MR. Comparion of outcomes of Laproscopic donor nephrectomy with Open donor nephrectomy, Indian Society of Organ Transplantation at Hyderabad 2003.
  6. Hegde UN,Gang SD, Rajapurkar MM Liver dysfunction after renal transplant; Significance of Positive HCV-RNA and absent Anti HCV-Antibody. Indian Society of Organ Transplantation at Hyderabad 2003.
  7. Durugkar SD,Hegde UN,Gang SD, Rajapurkar MM Outcome of renal transplantation in Diabetics(DM) : A comparison with matched non diabetic subjects. West Zone ISN at Pune2004.
  8. Dabhi M, Hegde UN,Gang SD, Rajapurkar MM CRP,IL-1β and TNF –α in patients on maintance hemodialysis and their correlation with albumin. Indian Society of Nephrology Varanasi 2004.
  9. Durugkar SD,Khanapet MS, Hegde UN ,Gang SD, Rajapurkar MM Detection of renal tubular lesion after IVU & renal angiography in kidney donors by brush border enzymes in the urine: Can N –Acetylcysteine (NAC) prevents it? – A Randomized prospective study. Indian Society of Nephrology Varanasi 2004.
  10. Hegde UN, Durugkar SD,Gang SD, Rajapurkar MM Renal transplantation  after myocardial revascularization in type II diabetics: still a matter of concern? Annual meeting of Indian Society of Organ Transplantation at Jaipur 2005.(Best poster award.)
  11. Hegde UN,Gang SD, Rajapurkar MM Laproscopic Donor nephrectomy: Recipient outcome stratified by donor age. Annual meeting of Indian Society of Organ Transplantation at Jaipur 2005.
  12. Aghgor N, Hegde UN,Gang SD, Rajapurkar MM Tunneled Cuffed catheters as vascular access in Hemodialysis : A single center experience. 36th Indian society of Nephrology at Cochin 2005.
  13. Aghgor N, Hegde UN,Gohel KD, Gang SD, Rajapurkar MM Vitamin D status in patients with chronic kidney disease. 36th Indian society of Nephrology at Cochin 2005.
  14.  Rajapurkar MM, Hegde UN, Gohel KD, Gang SD. Detection of renal tubular lesion after IVU & renal angiography (RA) in kidney donors by quantification of brush border enzymes in the urine: Can N –Acetylcysteine (NAC) prevents it? – A Randomized prospective study. American Society of Nephrology  Philidelphia USA  Nov 2005.
  15. Hegde UN,Gang SD, Gohel KD,Rajapurkar MM. Persistent liver disease in early post transplant period: significance of Positive HCV RNA & negative anti HCV-Ab. American Society of Nephrology at 
               San Dieago 2006 
  16. Rokhade MS,Hegde UN, Gohel KD, Gang SD, Rajapurkar MM Outcome of HbsAg positive renal transplant recipients. Annual meeting of West Zone chapter of Indian society of Nephrology at Mount Abu 2006.
  17. Kalani B,Hegde UN, Gohel KD, Gang SD, Rajapurkar MM Efficacy and safety of IL-2receptor antibody in living donor renal transplantation. Annual meeting of West Zone chapter of Indian society of Nephrology at Mount Abu 2006.
  18. Aghor N, Hegde UN, Gohel KD, Gang SD, Rajapurkar MM Outcome of immunosuppression with Tacrolimus to Cyclosporin: Single center experience. Annual meeting of Indian society of Nephrology at Bhuvaneshwar 2006.
  19. Aghor N, Hegde UN, Gohel KD, Gang SD, Rajapurkar MM Vitamin D status in patients with chronic kidney disease. Bone and Kidney symposium: International Society of Nephrology at Copenhagen 2006.
  20. Ijaz F, Sohail I,Hegde UN, Alam M.Efficacy of Hepatitis-B vaccination in patients on peritoneal dialysis. National Kidney Foundation spring clinical meeting   at Chicago 2007.
  21. Ijaz F, Sohail I,Hegde UN, Alam M. Automated peritoneal dialysis is associated with poor response to Hepatitis B vaccination.  National Kidney Foundation spring clinical meeting   at Chicago 2007.
  22. Gang SD, Aghor N, Hegde UN, Gohel KD, Rajapurkar MM. Vitamin D status in patients with chronic kidney disease. World Congress of Nephrology at Brazil 2007.
  23. Shewale K, Kalanl BH, Hegde UN, Gohel KD,Gang SD,Rajapurkar MM. Outcome of percutaneous intervention in transplant renal artery stenosis . Presented at Annual meeting of West-zone chapter of Indian society of Nephrology at Raipur 2007.
  24. Mavani S,Hegde UN, Gohel KD,Gang SD,Rajapurkar MM,Acharya VN. Efficacy and safety of sirolimus in chronic allograft nephropathy. Presented at Annual meeting of West-zone chapter of Indian society of Nephrology at Raipur 2007.
  25. Rokhade MS,Hegde UN, Gohel KD, Gang SD, Rajapurkar MM. Outcome of kidney transplantation in secondary renal amyloidosis: A single centre experience. Presented at Annual meeting of Indian Society of organ transplantation at Bangalore 2007.
  26. Mavani S,Hegde UN, Gohel KD,Gang SD,Rajapurkar MM,Acharya VN. Efficacy and safety of sirolimus in chronic allograft nephropathy. Presented at Annual meeting of Indian society of organ transplantation at Bangalore 2007.
  27. Gohel KD,Hegde UN, ,Gang SD,Rajapurkar MM. Malignancy after renal transplantation. Presented at Annual meeting of Indian society of organ transplantation at Bangalore 2007.
  28. Rajapurkar MM, Mittal B, Hegde UN, Bhallal HS, Shredhar S, Singh A Prevalence of anemia in India; The screening and Evaluation of Kidney Disease (SEEK) study. Presented at annual meeting of American Society of Nephrology 2007.
  29. Rajapurkar MM, Hegde UN, Gohel KD,Gang SD, Alam M ,Shah SV. Increased Bleomycin detectable iron after iodinated contrast. Presented at annual meeting of American Society of Nephrology 2007.
  30. Rokhade MS,Hegde UN, Gohel KD, Gang SD, Rajapurkar MM. Outcome of kidney transplantation in secondary renal amyloidosis: A single centre experience. Presented at Annual meeting of Indian Society of organ transplantation at Delhi 2007
  31. Kalani BH,Hegde UN, Gohel KD,Gang SD,Rajapurkar MM. Outcome of percutaneous intervention in transplant renal artery stenosis . Presented at Annual meeting of  Indian society of Nephrology at Delhi  2007
  32. Gohel KD,Hegde UN, ,Gang SD,Rajapurkar MM. Outcome of cytotoxic therapy in membranous nephropathy single center experience. Presented at Annual meeting of Indian society of Nephrology at Delhi 2007.
  33. Aghor N, Hegde UN, Gohel KD, Gang SD, Rajapurkar MM. The percutaneous intervention in non-atherosclerotic renal artery stenosis. Presented at Annual meeting of Indian society of Nephrology at Delhi 2007.
  34. Aghor N, Hegde UN, Gohel KD, Gang SD, Rajapurkar MM. The percutaneous intervention in atherosclerotic renal artery stenosis. Presented at Annual meeting of Indian society of Nephrology at Delhi 2007.
  35. Gang SD, Kalani BH , Hegde UN, Gohel KD, Rajapurkar MM Outcome of kidney transplantation in patients with type 2 Diabetes Mellitus: Impact of routine pretransplant coronary angiography and revascularization ISN Nexus Diabetes and Kidney Irland  July 2008
  36. Hegde UN, Gohel KD, Gang SD, Rajapurkar MM Post-transplant tuberculosis: Single center experience from the developing world at The Transplant Society –XXII international Conference at Sydney 2008.
  37. Gang SD, Kalani BH , Hegde UN, Gohel KD, Rajapurkar MM Outcome of kidney transplantation in patients with type 2 Diabetes Mellitus: Impact of routine pretransplant coronary angiography and revascularization. The Transplant Society –XXII international Conference at Sydney 2008.
  38. Gang SD, Kalani BH , Hegde UN, Gohel KD, Rajapurkar MM Outcome of kidney transplantation in patients with type 2 Diabetes Mellitus: Impact of routine pretransplant coronary angiography and revascularization. Presented at Annual meeting of Indian society of Nephrology at Pune 2008.
  39. Mavani S,Hegde UN, Gohel KD,Gang SD,Rajapurkar MM, Acharya VN . Emphysematous pyelonephritis: Factors deciding outcome and modality of treatment. Presented at Annual meeting of Indian society of Nephrology at Pune 2008.
  40. Hegde UN, Nagesh AA,Durugkar SD,Khanapet MS,Gohel KD, Gang SD, Rajapurkar MM RENO-VASCULAR HYPERTENSION SECONDARY TO AORTOARTERITIS: EXPERIENCE OF A TERTIARY CENTRE ” Presented at World Congress of Nephrology Milan, Italy, May 2009.
  41. Hegde UN, Mathew AM,Shewale K,Gohel KD, Gang SD, Rajapurkar MM CLINICAL PREDICTORS OF NON-DIABETIC RENAL DISEASE IN TYPE 2DIABETES MELLITUS.Presented at World Congress of Nephrology Milan,Italy,May2009.
  42. Hegde UN, Patel Archit,Mukhopadhyay B,Gohel KD, Gang SD,Lele SS, Rajapurkar MM SERUM CATALYTIC IRON AS A MARKER OF KIDNEY DISEASE AND COMORBIDITIES. Presented at World Congress of Nephrology Milan, Italy, May 2009
  43. Gohel K, , Hegde U, Gang S, Rajapurkar M, Outcome of paediatric renal transplant ;single center experience. Presented at World Congress of Nephrology Milan, Italy, May 2009
  44. Malvade T, Hegde UN, Patel Archit,Mukhopadhyay B,Gohel KD, Gang SD,Lele SS, Rajapurkar MM Serum catalytic iron as a marker of obstructive coronary artery disease in chronic Kidney Disease on hemodialysis. Presented at World Congress of Nephrology Milan, Italy, May 2009
  45. Mavani S,Hegde UN, Gohel KD,Gang SD,Rajapurkar MM, Acharya VN . Emphysematous pyelonephritis: Factors deciding outcome and modality of treatment. Presented at World Congress of Nephrology Milan, Italy, May 2009
  46. Mavani S,Hegde UN, Gohel KD,Gang SD,Rajapurkar MM, Acharya VN . Acute pyelonephritis in immunocompetent host. Presented at World Congress of Nephrology Milan, Italy, May 2009
  47. Konnur A,Hegde UN, ,Mukhopadhyay B,Gohel KD, Gang SD,Rajapurkar MM Serum catalytic iron as a marker of glomerular disease. Presented at World Congress of Nephrology Milan, Italy, May 2009
  48. Kansara M, Gohel K, , Hegde U, Gang S, Rajapurkar M “Prospective clinical study to assess serum catalytic iron as a marker of cardiovascular disease in Ckronic Kidney Disease.  Presented at Indian Society of Nephrology West Zone Chapter Goa   2009
  49. Konnur A,Hegde UN, ,Mukhopadhyay B,Gohel KD, Gang SD,Rajapurkar MM Serum catalytic iron as a marker of glomerular disease. Presented at Indian Society of Nephrology West Zone Chapter Goa   2009
  50. Mavani S,Hegde UN, Gohel KD,Gang SD,Rajapurkar MM, Acharya VN . Acute pyelonephritis in immunocompetent host. Presented at Indian Society of Nephrology West Zone Chapter Goa   2009
  51. Gohel K, , Hegde U, Gang S, Rajapurkar M, Outcome of second renal transplant ;single center experience. Presented at Indian Society of Nephrology Gauwhati December  2009
  52. Jayesh M,Hegde UN, Gohel KD,Gang SD, Rajapurkar MM. Dose dependent effect of parental iron sucrose on catalytic iron in patients on maintenance hemodialysis. Presented at Indian Society of Nephrology Gauwhati December 2009.
  53. Jayesh M, Hegde UN, Gohel KD,Gang SD, Rajapurkar MM. Dose dependent effect of parental iron sucrose on catalytic iron in patients on maintenance hemodialysis. Presented at ERA-EDTA congress Munich June 2010.
  54. Gohel KD, Hegde UN,Gang SD, Rajapurkar MM  Is MMF superior to Azathioprine in live donor transplantation Senario? ERA-EDTA congress Munich June 2010
  55. Gohel KD, Tripathi M,Hegde UN,Gang SD, Rajapurkar MM  Correlation of Pretransplant trough Tacrolimus lvel with early acute rejection in live donor renal transplantation. ERA-EDTA congress Munich June 2010
  56. Hegde UN, Patel A, Rajapurkar MM, Gohil F,Gang SD, Gohel KD, Prevalence of kidney disease among the Government employees of Nadiad, India Presented at APSN Seoul South Korea in Aril 2010
  57. Hegde UN Gohel KD, ,Gang SD, Rajapurkar MM  Comparison of Long-Term Outcomes between Spousal and Parental Donor renal Transplants: Single-Center Experience. Presented at Indian Society of Organ Transplantation Hyderabad  in Nov 2010
  58. Hegde UN, Patel Archit, Mukhopadhyay B,Gohel KD, Gang SD,Lele SS, Rajapurkar MM SERUM CATALYTIC IRON AS A MARKER OF KIDNEY DISEASE AND COMORBIDITIES. Presented at Indian Society of Nephrology, Cochin May 2010
  59. Jayesh M, Hegde UN, Gohel KD,Gang SD, Rajapurkar MM. Dose dependent effect of parental iron sucrose on catalytic iron in patients on maintenance hemodialysis. Presented at West Zone ISN  at Daman Oct  2010.
  60. Joshi Abhay, Hegde UN, Gohel KD,Gang SD,Rajapurkar SM,  Rajapurkar MM STUDY  OF  HEALTH RELATED QUALITY OF  LIFE  AMONG  PATIENTS ON MAINTAINANCE  HEMODIALYSIS  & IT’S ASSOCIATION   WITH  CLINICAL PARAMETERS presented at  ISN meeting Trivendrum Dec 2010
  61. Hegde UN, Patel Archit,Mukhopadhyay B,Gohel KD, Gang SD,Lele SS, Rajapurkar MM SERUM CATALYTIC IRON AS A MARKER OF KIDNEY DISEASE AND COMORBIDITIES. Presented at Indian Society  of Nephrology Trivendrum, Dec 2010
  62. Hegde UN Gohel KD, ,Gang SD, Ganju A, Dabhi M Rajapurkar MM  Comparison of Long-Term Outcomes between Spousal and Parental Donor renal Transplants: Single-Center Experience. Presented at Indian Society of Organ Transplantation Hyderabad  in Nov 2010
  63. Umapati Hegde, Mohan Rajapurkar, Mallikarjun Khanapet, Santosh Durugkar, Nagesh Aghor,Anil Ganju, Manish Dabhi, Kalpesh Gohel,Sishir Gang.Fifteen years experience of treating Atherosclerotic RenalArtery Stenosis by Interventional Nephrologists in India.Presented at World Congress of Nephrology  Vancouver,Canada, April 2011
  64. Umapati Hegde, Mohan Rajapurkar, Mallikarjun Khanapet, Santosh Durugkar, Nagesh Aghor,Anil Ganju, Manish Dabhi, Kalpesh Gohel,Sishir Gang.Fifteen years experience of treating Atherosclerotic Renal Artery Stenosis by Interventional Nephrologists in India. Presented at World Congress of Nephrology  Vancouver, Canada, April 2011
  65. Manish Dabhi,Umapati Hegde, Mohan Rajapurkar, Archit Patel, Kalpesh Gohel,Sishir Gang Prevalence of Chronic Kidney Disease in Adults in Western Part of INDIA Presented at World Congress of Nephrology  Vancouver,Canada, April 2011
  66. Gohel KD, Tripathi M,Hegde UN,Gang SD, Rajapurkar MM  Correlation of Pretransplant trough Tacrolimus lvel with early acute rejection in live donor renal transplantation. Presented at ASN-October 2011
  67. Gohel KD, Tripathi M,Hegde UN,Gang SD, Rajapurkar MM  Correlation of Pretransplant trough Tacrolimus lvel with early acute rejection in live donor renal transplantation. Presented at ISN-Hyderabad,Dec 2011
  68. Bhupesh K,Hegde UN,Gohel KD, ,Gang SD, Rajapurkar MM  Prospective randomized trial of Alcohol  as catheter locking solution in preventing catheter infection.Presented at ISN-WZ  ,Oct  2012
  69. Mishra P Hegde UN,Gohel KD, ,Gang SD, Rajapurkar MM  Study of urinary catalytic iron in Acute Coroonary Syndrome following Coronary interventions in Acute coronary syndrome  Presented at ISN-WZ  ,Oct  2012
  70. Hegde UN,Gohel KD, Mishra P,Gang SD, Rajapurkar MM  Study of urinary catalytic iron in Acute Coroonary Syndrome following Coronary interventions in Acute coronary syndrome  Presented at ISN-Ahmedabad ,Dec 2012
  71. Hegde UN, Ugale P Gohel KD,Gang SD, Rajapurkar MM  Effect of Renal transplant on Cardiac function assessed by Echocardiography ISOT  Bhubaneswar 2013
  72. Patel Anil, Hegde UN, Gohel KD, Gang SD, Rajapurkar MM  Prospective randomized trial comparing outcomes of Mycophenolate versus Azathioprine in renal transplant recipients.   Presented at ISOT Mumbai  2013
  73. Hegde UN, Gohel KD, Gang SD, Rajapurkar MM  Study of urinary catalytic iron in Acute Coroonary Syndrome following Coronary interventions in Acute coronary syndrome  Presented at WCN-Hongkong ,May  2013
  74. Goyal M,Hegde UN,Gohel KD, Gang SD, Rajapurkar MM   Effect of Renal transplant on Cardiac function assessed by Echocardiography Presented at IAN-Indore 2014
  75. Ghanawat Snehal,Hegde UN,Gohel KD, Gang SD, Rajapurkar MM   Outcome of post transplant HUS presented at ISOT Aurangabad  2014
  76. Jain Anurag, Hegde UN,Gohel KD, Gang SD, Rajapurkar MM   Outcome of interventions in AV fistula single center study ;Presented  at ISN west zone  2014
  77. Hegde UN,Mukhopadhyay B, Rajapurkar MM, Gang SD Hemodialysis induced release in plasma cell free hemoglobin as a source of catalytic iron in patients with End Stage Renal Disease Presented at EDTA London 2015.
  78. Jain A, UN,Gohel KD, Gang SD, Rajapurkar MM , Niacin as hypophosphaemic agent in CKD 3,4  . ISN WZ 2015 Nasik
  79. Ghanawat Snehal,Hegde UN,Gohel KD, Gang SD, Rajapurkar MM  Impact of catalytic iron in progression of CKD . ISN WZ 2015 Nasik
  80. Ghanawat Snehal, Hegde UN, Gohel KD, Gang SD, Rajapurkar MM  Impact of catalytic iron in progression of CKD . ISN  2015 Bangalore
  81. Patel Hardik ,Hegde  Gang SD, Rajapurkar MM   Urinary tract infection post transplant ; role of Nitrofurointoin in prevention prospective randomized trial  Presented at ISNWZ 2016 Indore 2016
  82. Chakurkar Vipul, Hegde UN , Mukhopadhyay,  Gang SD, Rajapurkar MM   Study of catalytic iron and other inflammatory  markers and their correlation  with cardiovascular events in maintenance hemodialysis.  Presented at ISNWZ 2016 Indore 2016
  83. Hegde UN ,Chakurkar Vipul.  Rajapurkar  MM, Gang SD,Mukhopadhyay B, Konnur Abhijit . Study of catalytic iron and other inflammatory  markers and their correlation  with cardiovascular events in maintenance hemodialysis.   Presented at EDTAERA Madrid June 2017.
  84. Dhamani Priyesh,  Hegde UN, Patel Hardik, Konnur Abhijit,,  Gang SD, Rajapurkar MM   Safety and efficacy of sofosbuvir based regimen in treatment of HCV infected renal transplant patients ; A Prospective; open label; single centre study  Presented at ISNWZ 2017 Surat
  85. Dhamani Priyesh,  Hegde UN ,Patel Hardik, Konnur Abhijit,,  Gang SD, Rajapurkar MM   Safety and efficacy of sofosbuvir based regimen in treatment of HCV infected renal transplant patients ; A Prospective; open label; single centre study  Presented at ISNWZ 2017 Surat
  86. Dharpawar Rohan,  Hegde UN ,Patel Hardik, Konnur Abhijit,,  Gang SD, Rajapurkar MM   A study of dialysis catheter related central vein stenosis. Presented at ISNWZ 2017 Surat
  87. Parikh Mithal ,  Hegde UN ,Patel Hardik, Konnur Abhijit,,  Gang SD, Rajapurkar MM    Outcome of Paediatric transplant ; Single centre experience  M P U Hospital  . Presented at ISOT Indore   2017
  88. Parikh Mithal ,  Hegde UN ,Patel Hardik, Konnur Abhijit,,  Gang SD, Rajapurkar MM    Outcome of Paediatric transplant ; Single centre experience  M P U Hospital  . Presented at Paediatric SN  2017
  89. Hegde UN, Dhamani Priyesh, Patel Hardik, Konnur Abhijit,,  Gang SD, Rajapurkar MM   Safety and efficacy of sofosbuvir based regimen in treatment of HCV infected renal transplant patients ; A Prospective; open label; single centre study  Presented at ISNWZ 2017 Surat
  90. Parikh Mithal ,  Hegde UN ,Patel HArdik, Konnur Abhijit,,  Gang SD, Rajapurkar MM    Outcome of Paediatric transplant ; Single centre experience  M P U Hospital  . Presented at Paediatric SN  2017

PUBLICATIONS: Papers and book chapters published

  1. Siddhesh Dhyagude,Umapati Hegde,Mohan Rajapurkar. Comorbidities and complications Associated with End Stage Renal Disease. ECAB Clinical Update: Nephrology, End Stage Renal Disease. Editor: Ravi Raju Tatapudi. 2011; 86-108.
  2. Rajpurkar MM, Hegde UN, Basic Hemodialysis Unit 2.Title: Electronics, electronic safety & setting up of dialysis machine . Post Doctoral Certificate in Dialysis Medicine, IGNOU 2011
  3. Rajpurkar MM, Hegde UN, Basic Hemodialysis Practical,Unit 2: Starting up of dialysis. Post Doctoral Certificate in Dialysis Medicine, IGNOU 2011
  4.  Rajpurkar MM, Hegde UN, Basic Hemodialysis,Unit3 . Title Trouble shooting with machine. Post Doctoral Certificate in Dialysis Medicine, IGNO U 2011
  5. Gokhale Y, Hegde U, Jyotish CJ “Classification and Diagnostic criteria for rheumatic disease” The Journal of General Medicine; 2002; 14(2); 7-14
  6. Gokhale Y, Hegde U, Hase NK et al  “Quadriplegia Complicating Ossification of the Posterior Longitudinal Ligament” J Assoc Physicians India 2002; 50:432-434
  7. Acharya VN, Hegde UN,  “Cytomegalovirus (CMV)-A threat to renal transplant patient” The Journal of General Medicine; 2004; 16(3) 67-70.
  8. Rajapurkar MM, Hegde UN, Balal S et al Indian Best practice guidelines –Vascular access – Indian Journal of Nephrology Dec 2005 supplement. Vol.No.15, No.3 (1)
  9. Rajapurkar MM, Hegde UN Gang SD, Rokde M, Gohel KD. Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure Nature Clinical Practice Nephrology. Nat Clin Pract Nephrol. 2007 Oct ;3 (10):573-7
  10. Gohel K, Khanpete M, Mukhopadhyaya B, Hegde U, Gang S, Rajapurkar M Subtle renal dysfunction after radiocontrast administration in prospective renal donors: Does N-acetylcysteine have a role in its prevention? Indian Journal of Nephrology 2007 17(4):160-164
  11. Hegde UN, Rajapurkar MM,Gang SD, Lele SS, Percutaneous  Endovascular management of recurrent aneurysm of transplant renal artery  anastomosed to internal iliac artery.  Indian J Urology.   2008:24:370-373.
  12. . Hegde UN, Khanapet MS,Rajapurkar MM, Gang SD,Gohel KD,Rane R,Parikh P,Patil D, Desai T ,Kelawala N,Patil P.Is Carbon Dioxide safe and good as alternative contrast for Diatrizoate Meglumine in Digital subtraction angiography? Indian J Nephrology 2009, 1:15-19.
  13. Mohan Rajapurkar , Dadyude Siddhesh  Hegde Umapati.  Comorbidities and complications associated with End stage renal disease  Elsevier  publications 2010
  14. Umapati Hegde, Mohan Rajapurkar,Mallikarjun Khanapet,Santosh Durugkar,Nagesh Aghor, Anil Ganju,Aghor,Anil Ganju,Manish Dabhi, Kalpesh Gohel,Sishir Gang . Fifteen years experience of treating Atherosclerotic Renal Artery Stenosis by an Interventional Nephrologists in India. Seminars in Dialysis 2011
  15. Rajapurkar MM,Shah SV,Lele SS, Hegde UN, Lensing SY,Gohel K,Mukhopadhyay B, Gang S, Eigenbrodt ML. Association of catalytic iron with cardiovascular disease. Am J Cardiol; 2012.
  16. Rajapurkar MM, Hegde UN, BatacharyaA, AlamMG, Shah SV Effect of Deferiprone, an oral iron chelator in diabetic and non-diabetic glomerular disease. Toxicol Mech Methods :23;5-10; 2013
  17. Rajapurkar MM, Lele SS, Malavade TS, Kansara MR, Hegde UN, Gohel KD, Gang SD,
     Shah SV,  Mukhopadhyay BN. Serum catalytic Iron: A novel biomarker for coronary artery   disease in patients   on maintenance hemodialysis. Indian J Nephro; 23;333-337; 2013
  18. Hegde UN, Rajapurkar MM, Banibrat M, Gang SD. Hemodialysis induced plasma cell free hemoglobin as a source of catalytic iron in patients with End stage renal disease .Nephrology Dialysis Transplantation 30(suppl_3):iii291-iii291 · May 2015

Trials/ Research conducted

  1. Efficacy of Cyclosporine microemulsion ( Arpimune ME prepared by RPG Life science) as immunosuppred agents in denovo renal transplant recipients. 2001.Co-founder investigator.
  2. Efficacy of erythropoietin from VHB – (EPO) in chronic kidney disease.
    Co-investigator.
  3. Efficacy of Sialogaue in reducing the thirst and interdialytic weight gain in Hemodailysis patients. Prospective, randomized, placebo controlled trial.
    Co-investigator
  4. Part of the Screening evaluation of early kidney disease in India, multicentric prospective cross-sectional survey.-Co-investigator
  5. A Multicentric, prospective, phase III clinical study to evaluate the efficacy and safety of Zydus  Recombinant Human Epoetin Alpha (r-HuEPO) in maintaining hemoglobin level in   Chronic Renal Failure (CRF)- Principal investigator.
  6. A single arm open label study to assess the efficacy, safety and tolerability of two weekly administration of intravenous MIRCERA for the treatment of chronic renal anemia in dialysis patients not currently treated with ESA. – Co-investigator.
  7. A double-blind, randomized, placebo-controlled multi-center trial to compare the phosphate lowering efficacy of different doses of SBR759 to placebo.-Co-investigator
  8. Evaluation of Efficacy and renal protection in Kidney transplantation. Multicentric, randomized controlled trial (Phase 3 trial) of Belatacept (LFA29Y) as immunosuppred agent in denovo renal transplant recipient. IM103008 . Co-investigator
  9. Evaluation of Efficacy and renal protection in Kidney transplantation. Multicentric, randomized controlled trial (Phase 3 trial) of Belatacept (LFA29Y) as immunosuppressive agent in Calcineurin withdrawal in stable renal transplant recipient. IM103010. Co-investigator
  10. A Multicentric, prospective, phase 4 clinical study to evaluate the efficacy and safety.  of    
  11. A Multicentric, prospective, phase III clinical study to evaluate the efficacy and safety of Reliance Recombinant Human Epoetin Alpha (r-HuEPO) in maintaining hemoglobin level  in  Chronic Renal Failure (CRF)- Principal investigator
  12. Phase 3 Multicenter open label,Active controlled study of the safety and efficacy of Roxadustat in the treatment of Anemia in dialysis patients. Principal  investigator
  13. Phase 3 Multicenter open label,Active controlled study of the safety and efficacy of Roxadustat in the treatment of Anemia in non-dialysis patients. Principal investigator
  14. Protocol # LRP/LNP1892/2016/007“A Randomized, Double – Blind, Placebo – Controlled, Phase 2 Study to Assess the Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of LNP1892 (Monotherapy) in Chronic Kidney Disease (CKD) Patients with Secondary Hyperparathyroidism (SHPT), On Dialysis and Not on Dialysis” Protocol”. Co-investigator
  15. A Multicenter, Multiple-dose, Active-controlled, Double-blind, Double‑dummy Study to Compare the Therapeutic Efficacy and Safety of Oral Doses of Cinacalcet Hydrochloride With Intravenous Doses of Etelcalcetide (AMG 416) in Asian Hemodialysis Subjects With Secondary Hyperparathyroidism Principal-investigator

Member of

  1. Indian Society of Nephrology
  2. Indian Society of Nephrology West zone chapter
  3. Indian Society of Organ Transplantation
  4. International Society of Nephrology
  5. American Society of Nephrology